Alfredo Pascual headshot
EMAIL: [email protected]
PHONE: 720.213.5971

Alfredo Pascual

Based in Germany, Alfredo specializes in international cannabis markets and regulations, drawing upon his extensive academic background in business and public policy. He founded Transnational Cannabis, a consultancy firm that focused on cannabis regulatory frameworks in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.

Colombian cannabis producers raise fresh rounds of capital

Some leading licensed cannabis producers in Colombia raised fresh rounds of capital recently. Khiron Life Sciences – a Toronto-based company with its main operations in Colombia – closed a bought deal for 14.5 million Canadian dollars ($11.5 million) that was disclosed Nov. 26. PharmaCielo, also headquartered in Toronto and operating primarily in Colombia, closed a […]

Read More

Argentina redraws medical cannabis rules, allowing home cultivation

Argentinian authorities published a new decree aiming to address the shortcomings of the rules governing the country’s medical cannabis sector, which has largely failed to materialize since an initial law and decree were approved in 2017. The new decree replaces the 2017 version, which did not facilitate meaningful access to medical cannabis and, by extension, […]

Read More

Germany’s medical cannabis flower market shows signs of cooling

Germany imported 1,759 kilograms (3,878 pounds) of medical cannabis flower for pharmacy dispensing during the third quarter of 2020, new data from the Federal Institute for Drugs and Medical Devices (BfArM) shows. This represents a 28% decrease over the previous quarter but is 34% lower than the same quarter last year. However, for the January-September period, […]

Read More

Argentina inches closer to first locally made cannabis medicine

Argentina might have the first locally-manufactured medical cannabis product as soon as early 2021. An official document shared by local pharmaceutical newspaper Pharmabiz shows that Manuel Limeres, head of Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT), authorized the company Laboratorio Alef Medical Argentina to register its Convupidiol product as a medicine. The […]

Read More

Epidiolex maker GW Pharma reports record quarterly revenue of $137 million

United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex. GW’s total revenue for the third quarter reached $137.1 million, about 16% more than the previous quarter’s $121.3 million. Epidiolex sales in the United States accounted for 87% of the company’s overall […]

Read More

Impact of US election on global cannabis sector to emerge slowly, executives say

Implications of the U.S. elections on the cannabis industry stretch far beyond America’s borders. (Click here for live coverage of the U.S. election results.) Industry executives in countries as far away as Australia, Jamaica and Uruguay are weighing how the results could affect their business prospects. Potential impacts include: Banking. How medical cannabis is controlled […]

Read More